Skip to main content
SpringerLink
Log in

Lokale Hemmung des Konversionsenzyms in Gefäßen durch Konversionsenzymhemmer: funktionelle und morphologische Aspekte

  • Conference paper
Blutdrucksenkung heute — Korrektur von Struktur und Funktion der Arterie

  • 19 Accesses

Zusammenfassung

Unser Wissen über blutdruckregulierende Hormonsysteme hat sich in den letzten Jahren sprunghaft erweitert. Dies gilt insbesondere für das Renin-Angiotensin-System (RAS).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Assad MM, Antanaccio MJ (1982) Vascular wall renin in spontaneously hypertensive rats. Hypertension 4: 487–493

    Article  Google Scholar 

  2. Campbell DJ, Habener JF (1986) Angiotensinogen gene as expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 78: 31–39

    Article  PubMed  CAS  Google Scholar 

  3. Chevillard C, Brown NL, Mathieu M-N, Laliberte F, Worcel M (1988) Differential effects of oral trandolapril and enalapril on rat tissue angiotensin-converting enzyme. Eur J Pharmacol 147: 23–28

    Article  PubMed  CAS  Google Scholar 

  4. Christensen LK, Jespersen LT, Mulvany MJ (1988) Therapeutic regression of resistance vessel structure in spontaneously hypertensive rats does not necessarily inhibit redevelopment of blood pressure on stopping treatment. (Proceedings of 12th Scientific Meeting of the International Society of Hypertension, Kyoto, Abstract 0189 )

    Google Scholar 

  5. Cohen ML, Kurz KD (1982) Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421. J Pharmacol Exp Ther 220: 63–69

    PubMed  CAS  Google Scholar 

  6. Cohen ML, Kurz KD, Schenk KW (1983) Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422. J Pharmacol Exper Ther 226: 192–196

    CAS  Google Scholar 

  7. Darby I, Aldred P, Crawford RJ, Fernley RT, Niall HD, Penschow JD, Ryan GB, Coghlan JP (1985) Gene expression in vessels of the ovine renal cortex. J Hypertension 3: 9–12

    Article  CAS  Google Scholar 

  8. Dzau VJ (1987) Vascular angiotensin pathways: a new therapeutic target. J Cardiovasc Pharmacol 10 (Suppl 7): S 9 — S16

    Article  Google Scholar 

  9. Dzau VJ, Safar ME (1988) Large conduit arteries in hypertension: role of the vascular renin-angiotensin system. Circulation 77: 947–954

    Article  PubMed  CAS  Google Scholar 

  10. Ganten D, Hayduk K, Brecht HM, Boucher R, Genest J (1970) Evidence of renin release or production in splanchnic territory. Nature 226: 551

    Article  PubMed  CAS  Google Scholar 

  11. Henrichs KJ, Unger Th, Berecek KH, Ganten D (1980) Is arterial media hypertrophy in spontaneously hypertensive rats a consequence of or a cause for hypertension. Clin Sci 59:331 s-333 s

    Google Scholar 

  12. Jackson B, Cubela R, Johnston C (1986) Angiotensin converting enzyme (ACE), characterization by 125I-MK351A binding studies of plasma and tissue ACE during variation of salt status in the rat. J Hypertension 4: 759–765

    Article  CAS  Google Scholar 

  13. Kuriyama S, Nakamura A, Hopp L, Fine BP, Kino M, Cragoe E Jr, Aviv A (1988) Angiotensin II effect on 22Na+-transport in vascular smooth muscle cells. J Cardiovasc Pharmacol 11: 139–146

    PubMed  CAS  Google Scholar 

  14. Longman SD, Howlett DR (1986) Angiotensin-converting enzyme responses following enalapril in the sodium deficient rat. Eur J Pharmacol 123: 379–386

    Article  PubMed  CAS  Google Scholar 

  15. Malik KU, Nasjletti A (1976) Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ Res 38: 26–30

    Article  PubMed  CAS  Google Scholar 

  16. Miyazaki M, Okunishi H, Mishimura K, Toda N (1984) Vascular angiotensin-converting enzyme activity in man and other species. Clin Sci 66: 39–45

    PubMed  CAS  Google Scholar 

  17. Nakamura Y, Nakamura K, Matsukura T (1988) Vascular angiotensin converting enzyme activity in spontaneously hypertensive rats and its inhibition with cilazapril. J Hypertension 6: 105–110

    Article  CAS  Google Scholar 

  18. Nakata K, Nishimura K, Takada T, Ikuse T, Yamauchi H, Iso T (1987) Effects of an angiotensin-converting enzyme ACE inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats. J Cardiovasc Pharmacol 9: 305–310

    Article  PubMed  CAS  Google Scholar 

  19. Nambu K, Matsumoto K, Takeyama K, Hosoki, Miyazaki H, Hashimoto M (1986) Tissue levels, tissue angiotensin converting enzyme inhibition and antihypertensive effect of the novel antihypertensive agent alacepril in renal hypertensive rats. Drug Res 36 (1): 47–51

    CAS  Google Scholar 

  20. Okunishi H, Miyazaki M, Okamura T, Toda N (1987) Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. Biochem Biophys Res Comm 149: 1186–1192

    Article  PubMed  CAS  Google Scholar 

  21. Oliver JA, Sciacca RR (1984) Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest 74: 1247–1251

    Article  PubMed  CAS  Google Scholar 

  22. Oshima T, Matsushita Y, Miyamoto M, Koike H (1983) Effects of long-term blockade of angiotensin converting enzyme with captopril on blood pressure and aortic prolyl hydroxylase activity in spontaneously hypertensive rats. Eur J Pharmacol 91: 283–286

    Article  PubMed  CAS  Google Scholar 

  23. Rosenthal J, Boucher R, Rojo Ortega JM, Genest J (1969) Renin activity in aortic tissue of rats. Can J Physiol Pharmacol 47: 53

    Article  PubMed  CAS  Google Scholar 

  24. Saye JA, Singer HA, Peach MJ (1984) Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta. Hypertension 6: 216–221

    PubMed  CAS  Google Scholar 

  25. Skidgel RA, Defendini R, Erdös EG (1988) Angiotensin I converting enzyme and its role in neuropeptide metabolism. In: Turner Ai (ed) Neuropeptides and their Peptidases. Horwood, Chichester, pp 165–188

    Google Scholar 

  26. Swales JD, Heagerty AM (1987) Vascular renin-angiotensin system: the unanswered questions. J Hypertension 5: S 1—S 5

    Google Scholar 

  27. Thurston H, Swales JD (1977) Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity. Clin Sci Mol Med 52: 299–304

    PubMed  CAS  Google Scholar 

  28. Thurston H, Swales JD, Bing RF, Hurst BC, Marks ES (1979) Vascular renin-like activity and blood pressure maintenance in the rat: Studies of the effect of changes in sodium balance, hypertension and nephrectomy. Hypertension 1: 643–649

    Google Scholar 

  29. Toda N (1984) Endothelium-dependent relation induced by angiotensin II and histamine in isolated arteries of dog. Br J Pharmacol 81: 301–307

    Article  PubMed  CAS  Google Scholar 

  30. Unger Th, Hübner D, Schüll B, Lang RE, Rascher W, Rettig R, Ganten D (1982) Effect of chronic oral captopril treatment on tissue renin concentration and converting enzyme activity in stroke-prone spontaneously hypertensive rats. In: Rascher W, Clough D, Ganten D (eds) Hypertensive Mechanisms. Schattauer, Stuttgart New York, pp 768 —773

    Google Scholar 

  31. Unger Th, Ganten D, Lang RE, Schölkens BA (1984 a) Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats. J Cardiovasc Pharmacol 6: 872–880

    Google Scholar 

  32. Unger Th, Fleck Th, Ganten D, Lang RE, Rettig R (1984b) 2-(N)-(S)-1-Ethoxycarbonyl-3-phenylpropyl-L-alamyl)-(1S,3S,5S)-2-azabicyclo (3.3.0)octane-3-carboxylic acid (Hoe498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats. Drug Res 34 (II): 1426–1430

    Google Scholar 

  33. Unger Th, Ganten D, Lang RE, Schölkens BA (1985) Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. J Cardiovasc Pharmacol 7: 36–41

    Article  PubMed  CAS  Google Scholar 

  34. Unger Th, Moursi M, Ganten D, Hermann K, Lang RE (1986 a) Antihypertensive action of the converting enzyme inhibitor perindopril (S9490–3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498). J Cardiovasc Pharmacol 8: 276–285

    Google Scholar 

  35. Unger Th, Ganten D, Lang RE (1986 b) Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors. J Cardiovasc Pharmacol 8 (Suppl 10): S 75—S 81

    Google Scholar 

  36. Unger Th, Gohlke P, Ganten D, Lang RE (1989) Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall. J Cardiovasc Pharmacol 13 (Suppl 3): S 8—S 16

    Google Scholar 

  37. Velletri P, Bean BL (1982) The effect of captopril on rat aortic angiotensin-converting enzyme. J Cardiovasc Pharmacol 4: 315–325

    Article  PubMed  CAS  Google Scholar 

  38. Wilson SK, Lynch DR, Snyder SH (1987) Angiotensin-converting enzyme labelled with [3H]Captopril. Tissue localization and changes in different models of hypertension in the rat. J Clin Invest 80: 841–851

    Google Scholar 

  39. Zimmermann BG (1981) Adrenergic facilitation by angiotensin: Does it serve a physiological function? Clin Sci 60: 343–348

    Google Scholar 

Download references

Authors
  1. Th. Unger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Gohlke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Poliklinik, Universität Bonn, Wilhelmstr. 35-37, W-5300, Bonn 1, Bundesrepublik Deutschland

    Klaus O. Stumpe

  2. Medizinische Klinik, Städtische Kliniken Dortmund, Beurhausstr. 40, W-4600, Dortmund 1, Bundesrepublik Deutschland

    Dieter Klaus

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Unger, T., Gohlke, P. (1990). Lokale Hemmung des Konversionsenzyms in Gefäßen durch Konversionsenzymhemmer: funktionelle und morphologische Aspekte. In: Stumpe, K.O., Klaus, D. (eds) Blutdrucksenkung heute — Korrektur von Struktur und Funktion der Arterie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85813-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85813-0_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53417-4

  • Online ISBN: 978-3-642-85813-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation